Italy Radiation Oncology Market Size & Outlook, 2020-2028

The radiation oncology market in Italy is expected to reach a projected revenue of US$ 444.8 million by 2028. A compound annual growth rate of 7.1% is expected of Italy radiation oncology market from 2021 to 2028.
Revenue, 2020 (US$M)
$256.3
Forecast, 2028 (US$M)
$444.8
CAGR, 2021 - 2028
7.1%
Report Coverage
Italy

Italy radiation oncology market highlights

  • The Italy radiation oncology market generated a revenue of USD 256.3 million in 2020 and is expected to reach USD 444.8 million by 2028.
  • The Italy market is expected to grow at a CAGR of 7.1% from 2021 to 2028.
  • In terms of segment, external beam radiationtherapy was the largest revenue generating type in 2020.
  • Internal Beam Radiation Therapy is the most lucrative type segment registering the fastest growth during the forecast period.


Radiation oncology market data book summary

Market revenue in 2020USD 256.3 million
Market revenue in 2028USD 444.8 million
Growth rate7.1% (CAGR from 2020 to 2028)
Largest segmentExternal beam radiationtherapy
Fastest growing segmentInternal Beam Radiation Therapy
Historical data2017 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationExternal Beam RadiationTherapy, Internal Beam Radiation Therapy
Key market players worldwideSiemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay


Other key industry trends

  • In terms of revenue, Italy accounted for 3.4% of the global radiation oncology market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Europe, Germany radiation oncology market is projected to lead the regional market in terms of revenue in 2028.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 500.6 million by 2028.

External beam radiationtherapy was the largest segment with a revenue share of 70.39% in 2020. Horizon Databook has segmented the Italy radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.


Increase in the number of radiation oncology centers in the country is estimated to propel the market growth. For instance, in April 2019, Koninklijke Philips N.V. announced the introduction of IntelliSpace Radiation Oncology to improve the efficiency of radiotherapy departments. 

Furthermore, in November 2018, the University of Pittsburgh Medical Center (UPMC) announced the opening of a radiotherapy center in the country. Growing disease burden is leading to an increase in the demand for radiation therapy, which is anticipated to drive the market growth. 

According to WHO, in 2018, around 409,808 new cancer cases were diagnosed, of which, 57,039 were breast cancer and 43,839 were prostate cancer cases. In addition, there are nearly 253 departments that use nuclear medicines, and about 24 of these departments are capable of producing radioisotopes.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Radiation Oncology Market Companies

Name Profile # Employees HQ Website

Italy radiation oncology market size, by type, 2017-2028 (US$M)

Italy Radiation Oncology Market Outlook Share, 2020 & 2028 (US$M)

Italy radiation oncology market size, by type, 2017-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more